Windtree Therapeutics Inc Market Cap ($6.74K)
Market Cap & Net Worth: Windtree Therapeutics Inc (WINT)
Windtree Therapeutics Inc market cap. Windtree Therapeutics Inc (NASDAQ:WINT) has a market capitalization of $6.74K ($6.74K) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31900 globally and #6425 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Windtree Therapeutics Inc's stock price $0.00 by its total outstanding shares 33708784 (33.71 Million). Also see Windtree Therapeutics Inc (WINT) cash conversion ratio for how efficiently the company converts equity into cash flow.
Windtree Therapeutics Inc Market Cap History (2015–2026)
Windtree Therapeutics Inc market cap history from 2015 to 2026. Data shows change from $5.45 Trillion to $6.74K (-85.27% CAGR). Check WINT stock price and chart for real-time trading data and today's change.
Index Memberships
Windtree Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #927 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #2920 of 3165 |
Weight: Windtree Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Windtree Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Windtree Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Windtree Therapeutics Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1953573.75x
Windtree Therapeutics Inc's market cap is 1953573.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.45 Trillion | $987.00K | -$55.17 Million | 5522779.93x | N/A |
| 2016 | $2.28 Trillion | $2.04 Million | -$39.49 Million | 1114269.91x | N/A |
| 2017 | $382.26 Billion | $1.49 Million | -$18.45 Million | 257412.07x | N/A |
| 2018 | $455.07 Billion | $1.79 Million | -$20.53 Million | 254512.16x | N/A |
| 2019 | $386.81 Billion | $198.00K | -$27.48 Million | 1953573.75x | N/A |
Competitor Companies of WINT by Market Capitalization
Companies near Windtree Therapeutics Inc in the global market cap rankings as of November 1, 2026. Also see Windtree Therapeutics Inc total assets for a full breakdown of the balance sheet.
Key companies related to Windtree Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Windtree Therapeutics Inc (2015–2026)
Market capitalization of Windtree Therapeutics Inc from 2015 to today. Between 2015 and today, Windtree Therapeutics Inc's market cap moved from $5.45 Trillion to $ 6.74K, with a yearly change of -85.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.74K | -99.43% |
| 2025 | $1.18 Million | -90.01% |
| 2024 | $11.77 Million | -97.30% |
| 2023 | $436.26 Million | -91.54% |
| 2022 | $5.16 Billion | -89.41% |
| 2021 | $48.69 Billion | -68.71% |
| 2020 | $155.63 Billion | -59.76% |
| 2019 | $386.81 Billion | -15.00% |
| 2018 | $455.07 Billion | +19.05% |
| 2017 | $382.26 Billion | -83.20% |
| 2016 | $2.28 Trillion | -58.26% |
| 2015 | $5.45 Trillion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Windtree Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.74K USD |
| MoneyControl | $6.74K USD |
| MarketWatch | $6.74K USD |
| marketcap.company | $6.74K USD |
| Reuters | $6.74K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Windtree Therapeutics Inc
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 sur… Read more